Wellington Management Group LLP Rhythm Pharmaceuticals, Inc. Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

A detailed history of Wellington Management Group LLP transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 27,716 shares of RYTM stock, worth $1.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,716

Previous 202,326 86.3%

Holding current value

$1.72 Million

Previous $8.31 Million 82.52%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$40.81 - $55.0 $7.13 Million - $9.6 Million	-174,610 Reduced 86.3%	27,716 $1.45 Million
Q2 2024 Aug 13, 2024	BUY	$35.41 - $44.37 $311,714 - $390,589	8,803 Added 4.55%	202,326 $8.31 Million
Q1 2024 May 15, 2024	BUY	$39.12 - $52.44 $7.57 Million - $10.1 Million	193,523 New	193,523 $8.39 Million
Q4 2023 Feb 12, 2024	BUY	$21.39 - $49.64 $2.99 Million - $6.94 Million	139,802 New	139,802 $6.43 Million
Q3 2023 Nov 14, 2023	SELL	$15.81 - $27.8 $43,920 - $77,228	-2,778 Reduced 1.98%	137,443 $3.15 Million
Q2 2023 Aug 14, 2023	BUY	$16.32 - $21.15 $466,556 - $604,636	28,588 Added 25.61%	140,221 $2.31 Million
Q1 2023 May 12, 2023	BUY	$16.88 - $34.24 $79,622 - $161,510	4,717 Added 4.41%	111,633 $1.99 Million
Q4 2022 Feb 13, 2023	SELL	$22.21 - $30.25 $1.03 Million - $1.4 Million	-46,297 Reduced 30.22%	106,916 $3.11 Million
Q3 2022 Nov 14, 2022	BUY	$4.3 - $30.85 $290,886 - $2.09 Million	67,648 Added 79.06%	153,213 $0
Q2 2022 Aug 15, 2022	SELL	$3.12 - $12.25 $767 - $3,013	-246 Reduced 0.29%	85,565 $355,000
Q1 2022 May 16, 2022	SELL	$6.13 - $12.24 $4.05 Million - $8.08 Million	-660,072 Reduced 88.5%	85,811 $989,000
Q4 2021 Feb 11, 2022	SELL	$8.62 - $13.9 $862,594 - $1.39 Million	-100,069 Reduced 11.83%	745,883 $7.44 Million
Q3 2021 Nov 15, 2021	SELL	$11.68 - $20.72 $5.26 Million - $9.33 Million	-450,129 Reduced 34.73%	845,952 $11 Million
Q2 2021 Aug 16, 2021	BUY	$18.52 - $22.55 $5.2 Million - $6.33 Million	280,779 Added 27.65%	1,296,081 $25.4 Million
Q1 2021 May 17, 2021	SELL	$20.25 - $39.49 $22 Million - $42.9 Million	-1,085,925 Reduced 51.68%	1,015,302 $21.6 Million
Q4 2020 Feb 12, 2021	SELL	$21.17 - $32.61 $5.78 Million - $8.91 Million	-273,121 Reduced 11.5%	2,101,227 $62.5 Million
Q3 2020 Nov 16, 2020	SELL	$18.13 - $30.61 $4.04 Million - $6.81 Million	-222,575 Reduced 8.57%	2,374,348 $51.5 Million
Q2 2020 Aug 14, 2020	SELL	$14.41 - $25.35 $1.03 Million - $1.81 Million	-71,305 Reduced 2.67%	2,596,923 $57.9 Million
Q1 2020 May 14, 2020	SELL	$13.16 - $22.9 $8.59 Million - $14.9 Million	-652,523 Reduced 19.65%	2,668,228 $40.6 Million
Q4 2019 Feb 11, 2020	BUY	$19.53 - $25.5 $64.9 Million - $84.7 Million	3,320,751 New	3,320,751 $76.2 Million

Others Institutions Holding RYTM

# of Institutions

192

Shares Held

67.3M

Call Options Held

834K

Put Options Held

78.6K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.46B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Rhythm Pharmaceuticals, Inc. Transaction History